Related Experiment Videos
[The prevention of inflammatory complications from uranoplasty by using the baliz-2 preparation]
Stomatologiia
|March 1, 1991
Insights
Baliz-2 effectively prevented nasopharyngeal infections in children undergoing uranoplasty. This new antibacterial drug reduced postoperative inflammatory complications in patients with palatal clefts.
Area of Science:
- Bacteriology
- Pediatric Surgery
- Pharmacology
Background:
- Nasopharyngeal infections are a common complication following uranoplasty.
- Palatal clefts present unique challenges in pediatric surgical procedures.
- Effective infection prevention is crucial for optimal surgical outcomes in children.
Purpose of the Study:
- To evaluate the efficacy of Baliz-2 in preventing nasopharyngeal infections.
- To assess the impact of Baliz-2 on postoperative inflammatory complications after uranoplasty.
- To determine the sanitation effect of Baliz-2 in pediatric patients.
Main Methods:
- A study involving 25 children with palatal clefts undergoing uranoplasty.
- Administration of Baliz-2 pre- and post-surgery.
- Monitoring for nasopharyngeal infections and inflammatory complications.
Main Results:
- Baliz-2 demonstrated a significant sanitation effect.
- A reduced incidence of postoperative inflammatory complications was observed.
- The drug proved effective in preventing nasopharyngeal infection.
Conclusions:
- Baliz-2 is a promising antibacterial agent for preventing nasopharyngeal infections in pediatric uranoplasty.
- The use of Baliz-2 can decrease the rate of postoperative inflammatory complications.
- Further research into Baliz-2's application in pediatric surgical prophylaxis is warranted.
Abstract:
Baliz-2, a new antibacterial drug, was used to prevent nasopharyngeal infection before and after uranoplasty in 25 children with palatal clefts. Sanitation effect of the drug was revealed; the incidence of postoperative inflammatory complications was reduced.